- Company Overview for PHARMACYX LTD (12645182)
- Filing history for PHARMACYX LTD (12645182)
- People for PHARMACYX LTD (12645182)
- More for PHARMACYX LTD (12645182)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
05 Sep 2024 | AA | Total exemption full accounts made up to 31 March 2024 | |
11 Jul 2024 | CS01 | Confirmation statement made on 3 June 2024 with updates | |
25 Sep 2023 | PSC01 | Notification of Paul Robert Mayberry as a person with significant control on 1 April 2023 | |
25 Sep 2023 | SH01 |
Statement of capital following an allotment of shares on 1 April 2023
|
|
16 Aug 2023 | AA | Unaudited abridged accounts made up to 31 March 2023 | |
13 Jul 2023 | PSC04 | Change of details for Benjamin Drew Mayberry as a person with significant control on 6 June 2021 | |
21 Jun 2023 | CS01 | Confirmation statement made on 3 June 2023 with no updates | |
21 Nov 2022 | AAMD | Amended accounts made up to 31 March 2022 | |
09 Aug 2022 | AA | Unaudited abridged accounts made up to 31 March 2022 | |
09 Jun 2022 | CS01 | Confirmation statement made on 3 June 2022 with no updates | |
30 Dec 2021 | AA | Micro company accounts made up to 31 March 2021 | |
08 Dec 2021 | CERTNM |
Company name changed mbbm healthcare technologies LTD\certificate issued on 08/12/21
|
|
25 Jun 2021 | AA01 | Previous accounting period shortened from 30 June 2021 to 31 March 2021 | |
25 Jun 2021 | CS01 | Confirmation statement made on 3 June 2021 with updates | |
28 Apr 2021 | AP01 | Appointment of Mr Matthew Kenneth John Bridges as a director on 28 April 2021 | |
28 Apr 2021 | PSC01 | Notification of Matthew Kenneth John Bridges as a person with significant control on 6 June 2020 | |
04 Jun 2020 | NEWINC |
Incorporation
Statement of capital on 2020-06-04
|